Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$519M |
| 2 |
Netflix
NFLX
|
+$448M |
| 3 |
Qualcomm
QCOM
|
+$280M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Broadcom
AVGO
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$453M |
| 2 |
ExxonMobil
XOM
|
+$234M |
| 3 |
GMS
GMS Inc
GMS
|
+$217M |
| 4 |
SKX
Skechers
SKX
|
+$201M |
| 5 |
Capital One
COF
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 17.99% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Healthcare | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
National Bankshares
NKSH
$244M
| $3.59M | ﹤0.01% |
122,055
+2,492
| +2% | +$73.7K |
|
2627
James Hardie Industries
JHX
$15.5B
| $3.59M | ﹤0.01% |
187,131
+123,442
| +194% | +$2.96M |
|
|
GLIBA
2628
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$915M
| $3.57M | ﹤0.01% |
+94,983
| New | +$3.37M |
|
2629
PLDT
PHI
$4.26B
| $3.56M | ﹤0.01% |
190,307
-3,349
| -2% | -$71.9K |
|
2630
BridgeBio Pharma
BBIO
$16.5B
| $3.55M | ﹤0.01% |
68,253
-33,534
| -33% | -$1.64M |
|
2631
Clarus
CLAR
$126M
| $3.52M | ﹤0.01% |
1,005,507
-80,219
| -7% | -$290K |
|
2632
FVCBankcorp
FVCB
$328M
| $3.51M | ﹤0.01% |
270,990
+7,705
| +3% | +$101K |
|
2633
Ohio Valley Banc Corp
OVBC
$202M
| $3.51M | ﹤0.01% |
94,811
-528
| -0.6% | -$18.8K |
|
|
CYBR
2634
DELISTED
CyberArk
CYBR
| $3.48M | ﹤0.01% |
7,193
+798
| +12% | +$343K |
|
2635
Kingstone Companies
KINS
$285M
| $3.43M | ﹤0.01% |
233,343
-2,514
| -1% | -$36.9K |
|
2636
Stratasys
SSYS
$700M
| $3.42M | ﹤0.01% |
305,190
-313,083
| -51% | -$3.37M |
|
2637
Taylor Devices
TAYD
$178M
| $3.4M | ﹤0.01% |
69,326
+1,153
| +2% | +$53.5K |
|
2638
Norwood Financial Corp
NWFL
$367M
| $3.39M | ﹤0.01% |
133,309
+6,148
| +5% | +$157K |
|
2639
Aldeyra Therapeutics
ALDX
$95.6M
| $3.38M | ﹤0.01% |
648,371
-70,342
| -10% | -$367K |
|
2640
Energy Services of America
ESOA
$296M
| $3.36M | ﹤0.01% |
324,780
+3,952
| +1% | +$39.9K |
|
2641
AmeriServ Financial
ASRV
$71.1M
| $3.36M | ﹤0.01% |
1,158,433
-7,823
| -0.7% | -$23.4K |
|
2642
Silvercrest Asset Management
SAMG
$80.2M
| $3.36M | ﹤0.01% |
213,053
-5,318
| -2% | -$86.7K |
|
2643
Cato Corp
CATO
$64.1M
| $3.3M | ﹤0.01% |
784,893
-36,865
| -4% | -$130K |
|
|
TRML
2644
DELISTED
Tourmaline Bio
TRML
| $3.3M | ﹤0.01% |
69,085
-44,806
| -39% | -$1.24M |
|
2645
EVI Industries
EVI
$183M
| $3.3M | ﹤0.01% |
104,380
+852
| +0.8% | +$22.3K |
|
2646
Enliven Therapeutics
ELVN
$3.77B
| $3.28M | ﹤0.01% |
160,459
+113,608
| +242% | +$2.29M |
|
2647
EyePoint Inc
EYPT
$1.04B
| $3.26M | ﹤0.01% |
229,087
+159,125
| +227% | +$1.83M |
|
2648
Eagle Bancorp Montana
EBMT
$187M
| $3.24M | ﹤0.01% |
187,849
+5,324
| +3% | +$90.7K |
|
2649
Enanta Pharmaceuticals
ENTA
$370M
| $3.24M | ﹤0.01% |
270,068
-7,572
| -3% | -$60.5K |
|
2650
Editas Medicine
EDIT
$411M
| $3.23M | ﹤0.01% |
931,910
-472,808
| -34% | -$1.32M |
|
Similar funds
Dimensional Fund Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Dimensional Fund Advisors held 3,356 positions worth $466B, up 7.9% from $432B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q3 2025 filing shows 84 new, 1,582 increased, 1,511 reduced and 85 closed positions. Its largest new stake was Qiagen: 1,300,037 shares worth $58.1M. The largest sale was Hess, an estimated $453M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2025 buy was Qiagen: 1,300,037 shares worth $58.1M.
- Dimensional Fund Advisors added most to Chevron in Q3 2025, an estimated $519M increase.
- Dimensional Fund Advisors's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $234M.
- Dimensional Fund Advisors fully exited Hess in Q3 2025, selling an estimated $453M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $466B portfolio in Q3 2025.
- Dimensional Fund Advisors opened 84 new positions and closed 85 in Q3 2025.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $466B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.